JACOBSON KENNETH A has a total of 11 patent applications. Its first patent ever was published in 1991. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and engines, pumps and turbines are XOC PHARMACEUTICALS INC, NIKEM RESEARCH SRL and 4SC DISCOVERY GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 4 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Engines, pumps and turbines | |
#4 | Transport |
# | Name | Total Patents |
---|---|---|
#1 | Jacobson Kenneth A | 11 |
#2 | Tosh Dilip K | 3 |
#3 | Melman Artem | 3 |
#4 | Wang Ben Bih-Ren | 2 |
#5 | Kim Yong-Chul | 2 |
#6 | Hechler Beatrice | 1 |
#7 | Linden Joel M | 1 |
#8 | Van Rhee Albert M | 1 |
#9 | Kim Yoonkyung | 1 |
#10 | Karton Yishai | 1 |
Publication | Filing date | Title |
---|---|---|
US2012252823A1 | Adenosine receptor agonists, partial agonists, and antagonists | |
US2012184569A1 | A3 adenosine receptor agonists and antagonists | |
US2012264769A1 | Methanocarba adenosine derivatives, pharmaceutical compositions, and method of reducing intraocular pressure | |
US2011171130A1 | A3 adenosine receptor antagonists and partial agonists | |
US2011046166A1 | Purine derivatives as A3 adenosine receptor-selective agonists | |
WO9727177A2 | Dihydropyridine-, pyridine-, benzopyran-4-one- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists | |
US5178565A | Lower unit guard |